ENTITY
Guangzhou Baiyunshan Pharmaceutical Holdings

Guangzhou Baiyunshan Pharmaceutical Holdings (874 HK)

94
Analysis
Health CareChina
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. manufactures and sells Chinese patent medicine. The Company also wholesales, retails, imports, and exports Western and Chinese pharmaceutical products and various medical apparatus.
more
03 Nov 2024 10:05

A-H Premium Weekly (Nov 1st):Chalco, ZOOMLION, FDZJ, FLAT GROUP, RemeGen, CanSinoBIO

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Chalco, ZOOMLION, FDZJ, FLAT GROUP, RemeGen, CanSinoBIO.

Logo
211 Views
Share
18 Oct 2024 23:12

China Traditional Chinese Medicine (570 HK): Disaster as Offer Lapses, Potential Deal Break Price

This deal break caught many, including me, off guard. There are lessons to be learnt and questions to be asked. Shareholders will have a bruising...

Logo
1k Views
Share
17 Oct 2024 00:34

China Traditional Chinese Medicine (570 HK): Theatre of the Absurd

The update will do little to soothe frayed nerves. The extension will be forthcoming as the delay is procedural, there is a reputational risk from...

Logo
610 Views
Share
09 Oct 2024 14:13

China Traditional Chinese Medicine (570 HK): Never a Dull Moment as Profit Warning Lands

According to the Beijing Municipal Government website, China TCM has received unconditional approval from SAMR. This news was largely expected and...

Logo
992 Views
Share
16 Aug 2024 01:32

China Traditional Chinese Medicine (570 HK): Relief as Update Favours the Bulls

The monthly update will relieve the bulls, but there remain potential stumbling blocks. Nevertheless, the risk vs. reward remains attractive.

Logo
466 Views
Share
x